For patients with initially resectable colorectal liver metastases, the survival benefits of NAC are still unclear.
Nevertheless, the mechanisms underlying the therapeutic and clinical applications of NAC are not fully understood.
Moreover, in more recent meta-analyses positive results favouring NAC are demonstrated only when they include published trials.
Potential disadvantages of NAC are the inherent risk of disease progression preoperatively and the risk of liver toxicity.
In conclusion, the survival benefits of NAC are still unclear for patients with initially resectable colorectal liver metastases.
Meanwhile, the implications of having residual urothelial carcinoma of the bladder (rUCB) at RC after NAC are less clear.
As an antioxidant and anti-inflammatory agent the protective effects of N-acetylcysteine (NAC) are documented in several studies.
The anticarcinogenic properties of NAC are attributed to multiple protective mechanisms, such as its nucleophilicity, antioxidant activity and inhibition of DNA adduct formation [92, 93].
These errors with NAC are well described, with systemic calculation errors occurring in 5% of cases, mixing errors in 9%, and measuring errors in 3%[12]].
Among these contaminants, nitroaromatic compounds (NAC) are considered to be highly toxic as they exhibit serious carcinogenic and mutagenic threats to human health [30].
These observations provide evidence that cannabinoid CB1 receptors in the NAc are involved in development of reward-related behaviors and they can potentiate the rewarding effects of morphine.
